VolenteDx delivers precise and actionable results that providers and physicians need to treat patients more effectively.
VolenteDx is the only lab that utilizes infectious disease-trained PharmDs in developing the best therapeutic plan for each patient.
In a study1 using molecular diagnostics and personalized medicine in wound care, the following outcomes were found:
- In the “Standard of Care Group,” utilizing traditional culture and sensitivity testing with systemic antibiotics, 48.5% of patients healed. (244/503)
- In “Group I,” utilizing molecular diagnostics with systemic antibiotics, 62.4% of patients healed. (298/479)
- In “Group II,” utilizing molecular diagnostics with customized topical antibiotics, 90.4% of patients healed. (358/396)
- Molecular diagnostics and personalized medicine in wound care: assessment of outcomes. S.E.Dowd, R.D.Wolcott, J.Kennedy, C.Jones, and S.B.Cox. Journal of Wound Care 2011 20:5, 232-239